137 related articles for article (PubMed ID: 37006066)
41. Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial.
Tao Y; Auperin A; Blanchard P; Alfonsi M; Sun XS; Rives M; Pointreau Y; Castelli J; Graff P; Wong Hee Kam S; Thariat J; Veresezan O; Heymann S; Renard-Oldrini S; Lafond C; Cornely A; Casiraghi O; Boisselier P; Lapeyre M; Biau J; Bourhis J
Radiother Oncol; 2020 Sep; 150():18-25. PubMed ID: 32417348
[TBL] [Abstract][Full Text] [Related]
42. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
43. Volumetric-modulated arc therapy in head and neck radiotherapy: a planning comparison using simultaneous integrated boost for nasopharynx and oropharynx carcinoma.
Johnston M; Clifford S; Bromley R; Back M; Oliver L; Eade T
Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):503-11. PubMed ID: 21397477
[TBL] [Abstract][Full Text] [Related]
44. Real-life efficacy of volumetric modulated arc therapy in head and neck squamous cell carcinoma.
Moncharmont C; Vallard A; Guy JB; Prades JM; Rancoule C; Magné N
Eur Ann Otorhinolaryngol Head Neck Dis; 2017 May; 134(3):165-169. PubMed ID: 28034705
[TBL] [Abstract][Full Text] [Related]
45. Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial.
Gupta T; Sinha S; Ghosh-Laskar S; Budrukkar A; Mummudi N; Swain M; Phurailatpam R; Prabhash K; Agarwal JP
Radiat Oncol; 2020 Sep; 15(1):218. PubMed ID: 32938468
[TBL] [Abstract][Full Text] [Related]
46. Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.
van den Bosch S; Dijkema T; Kunze-Busch MC; Terhaard CH; Raaijmakers CP; Doornaert PA; Hoebers FJ; Vergeer MR; Kreike B; Wijers OB; Oyen WJ; Kaanders JH
BMC Cancer; 2017 Mar; 17(1):208. PubMed ID: 28327089
[TBL] [Abstract][Full Text] [Related]
47. Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients.
Alongi F; Bignardi M; Garassino I; Pentimalli S; Cavina R; Mancosu P; Reggiori G; Poletti A; Ferrari D; Foa P; Bigoni A; Dragonetti A; Salvatori P; Spahiu O; Fogliata A; Cozzi L; Santoro A; Scorsetti M
Strahlenther Onkol; 2012 Jan; 188(1):49-55. PubMed ID: 22194030
[TBL] [Abstract][Full Text] [Related]
48. Moderately Hypofractionated Intensity-modulated Radiotherapy With a Simultaneous Integrated Boost for Locally Advanced Head and Neck Cancer - Do Modern Techniques Fulfil Their Promise?
Wichmann J; Durisin M; Hermann RM; Merten R; Christiansen H
In Vivo; 2021; 35(5):2801-2808. PubMed ID: 34410971
[TBL] [Abstract][Full Text] [Related]
49. Comparison of whole-field simultaneous integrated boost VMAT and IMRT in the treatment of nasopharyngeal cancer.
Jin X; Yi J; Zhou Y; Yan H; Han C; Xie C
Med Dosim; 2013; 38(4):418-23. PubMed ID: 23973017
[TBL] [Abstract][Full Text] [Related]
50. Optimal VMAT Delivery for Elekta MLC Beam Modulator: A Study of Collimator Rotation for Head and Neck Planning.
Murtaza G; Mehmood S; Silvia Favretto M; Cora S
J Med Imaging Radiat Sci; 2020 Jun; 51(2):289-298. PubMed ID: 32229103
[TBL] [Abstract][Full Text] [Related]
51. Is there room for combined modality treatments? Dosimetric comparison of boost strategies for advanced head and neck and prostate cancer.
Góra J; Hopfgartner J; Kuess P; Paskeviciute B; Georg D
J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i97-112. PubMed ID: 23824134
[TBL] [Abstract][Full Text] [Related]
52. Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer.
Cilla S; Caravatta L; Picardi V; Sabatino D; Macchia G; Digesù C; Deodato F; Massaccesi M; De Spirito M; Piermattei A; Morganti AG
Clin Oncol (R Coll Radiol); 2012 May; 24(4):261-8. PubMed ID: 21820294
[TBL] [Abstract][Full Text] [Related]
53. Dual arc volumetric-modulated arc radiotherapy (VMAT) of nasopharyngeal carcinomas: a simultaneous integrated boost treatment plan comparison with intensity-modulated radiotherapies and single arc VMAT.
Lee TF; Ting HM; Chao PJ; Fang FM
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):196-207. PubMed ID: 21752615
[TBL] [Abstract][Full Text] [Related]
54. Dosimetric and radiobiological comparison of simultaneous integrated boost and sequential boost of locally advanced cervical cancer.
Sukhikh ES; Sukhikh LG; Lushnikova PA; Tatarchenko MA; Abdelrahman AR
Phys Med; 2020 May; 73():83-88. PubMed ID: 32334401
[TBL] [Abstract][Full Text] [Related]
55. Implementation of intensity-modulated radiotherapy for head and neck cancers in routine practice.
Bednarek C; Nguyen TV; Puyraveau M; Bonnet É; Lescut N; Azélie C; Miny J; Mauvais O; Maurina T; Tochet F; Bosset JF; Thariat J; Sun XS
Cancer Radiother; 2017 Feb; 21(1):21-27. PubMed ID: 28034680
[TBL] [Abstract][Full Text] [Related]
56. Dosimetric Comparison and Feasibility of Simultaneous Integrated Boost (SIB) in Treatment of Malignant Gliomas Using Intensity Modulated Radiotherapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT).
Rapole PS; Karunanithi G; Kandasamy S; Prabhu S; Kumar R; Vivekanandam S
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2499-2506. PubMed ID: 30256043
[TBL] [Abstract][Full Text] [Related]
57. IMRT-SIB with concurrent and neo-adjuvant platinum-based chemotherapy for locally advanced head and neck squamous cell cancer: analysis of clinical outcomes in a retrospective series of a single institution.
Mazzeo E; Antognoni P; Parmiggiani M; D'Ambrosio C; De Marco G; Marra L; Gottardi G; Bertoni F
Tumori; 2014; 100(6):652-9. PubMed ID: 25688499
[TBL] [Abstract][Full Text] [Related]
58. Impact of MLC leaf width on volumetric-modulated arc therapy planning for head and neck cancers.
Lafond C; Chajon E; Devillers A; Louvel G; Toublanc S; Olivier M; Simon A; De Crevoisier R; Manens JP
J Appl Clin Med Phys; 2013 Nov; 14(6):4074. PubMed ID: 24257269
[TBL] [Abstract][Full Text] [Related]
59. Neoadjuvant volumetric modulated arc radiochemotherapy with a simultaneous integrated boost technique compared to standard chemoradiation for locally advanced rectal cancer.
Jankarashvili N; Kakhadze S; Topeshashvili M; Turkiasvili L; Tchiabrishvili M
Turk J Med Sci; 2019 Oct; 49(5):1484-1489. PubMed ID: 31651118
[TBL] [Abstract][Full Text] [Related]
60. Simultaneous integrated boost therapy of carcinoma of the hypopharynx/larynx with and without flattening filter - a treatment planning and dosimetry study.
Dobler B; Obermeier T; Hautmann MG; Khemissi A; Koelbl O
Radiat Oncol; 2017 Jul; 12(1):114. PubMed ID: 28679448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
